- Home
- XBP vs CASI Comparison
XBP vs CASI Comparison
Compare XBP & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- CASI
- Stock Information
- Founded
- XBP N/A
- CASI 1991
- Country
- XBP United Kingdom
- CASI China
- Employees
- XBP N/A
- CASI N/A
- Industry
- XBP Business Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- XBP Consumer Discretionary
- CASI Health Care
- Exchange
- XBP Nasdaq
- CASI Nasdaq
- Market Cap
- XBP 40.1M
- CASI 33.4M
- IPO Year
- XBP N/A
- CASI 1996
- Fundamental
- Price
- XBP $1.30
- CASI $2.10
- Analyst Decision
- XBP
- CASI Strong Buy
- Analyst Count
- XBP 0
- CASI 1
- Target Price
- XBP N/A
- CASI $6.00
- AVG Volume (30 Days)
- XBP 40.3K
- CASI 8.5K
- Earning Date
- XBP 03-19-2025
- CASI 03-31-2025
- Dividend Yield
- XBP N/A
- CASI N/A
- EPS Growth
- XBP N/A
- CASI N/A
- EPS
- XBP N/A
- CASI N/A
- Revenue
- XBP $142,772,000.00
- CASI $28,537,000.00
- Revenue This Year
- XBP N/A
- CASI N/A
- Revenue Next Year
- XBP N/A
- CASI $134.79
- P/E Ratio
- XBP N/A
- CASI N/A
- Revenue Growth
- XBP N/A
- CASI N/A
- 52 Week Low
- XBP $0.79
- CASI $2.04
- 52 Week High
- XBP $4.33
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- XBP 54.08
- CASI 42.35
- Support Level
- XBP $1.19
- CASI $2.10
- Resistance Level
- XBP $1.38
- CASI $2.52
- Average True Range (ATR)
- XBP 0.14
- CASI 0.21
- MACD
- XBP 0.01
- CASI 0.00
- Stochastic Oscillator
- XBP 78.78
- CASI 12.50
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.